1. Home
  2. |Insights
  3. |Food and Drug Law Institute 2nd Annual Conference on Nanotechnology Law, Regulation and Policy

Food and Drug Law Institute 2nd Annual Conference on Nanotechnology Law, Regulation and Policy

Event | 02.18.09 - 02.19.09, 12:00 AM UTC - 12:00 AM UTC

While the overall economy may be faltering, nanotechnology continues on the upswing. In the next five years, the nanotechnology market is expected to grow to almost $3 trillion. Nanotechnology products are found in all sectors of the food and drug industry, including pharmaceuticals, devices, sunscreens, cosmetics, supplements and food.

At FDLI’s landmark 1st Annual Conference on Nanotechnology Law, Regulation and Policy in February 2008, attendees heard from top officials from FDA and other government agencies to find out their plans for regulating food and drug nanotech products. Now, at the 2nd Annual Conference, attendees get an opportunity — for the first time— to hear directly from officials from the Obama Administration and the new Congress on their regulatory plans.

Matthew Jaffe will speak on the Business of Nanotechnology and James Chen will speak on Safety Issues.

For more information, please visit these areas: Environment and Natural Resources

Insights

Event | 02.20.25

Has the Buss Stopped? Recoupment Today

Has the Buss Stopped? Recoupment Today: In 1997, the California Supreme Court decided Buss v. Superior Court. In Buss, the court concluded that a liability insurer that defended a mixed action could seek reimbursement from the insured for the defense costs associated with the claims that were not even potentially covered. Since then, numerous courts have held that insurers are entitled to recoup their defense costs associated with uncovered claims or causes of action. On the other hand, a significant number of courts have rejected insurers’ right to recoupment, at least in the absence of a policy provision granting the insurer that right. Some commentators have even suggested that the current judicial trend might be away from permitting insurers to recoup their defense costs. Is that correct? Has the Buss stopped? This panel of coverage experts will analyze insurers’ claimed right to recoupment today, and offer their perspectives on what the law on recoupment should perhaps be and might be in the future.